A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).
Clinical trial NCT03923738 · COMPLETED
Trial details
- NCT number
- NCT03923738
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-05
- Primary completion
- 2020-11-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.